BioLife Solutions, Inc.
BLFS
$23.95
-$0.79-3.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 103.92% | -3,435.27% | -103.60% |
| Total Depreciation and Amortization | -- | -- | -3.40% | 170.98% | -70.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -67.17% | 300.57% | 140.58% |
| Change in Net Operating Assets | -- | -- | -3,616.47% | 102.26% | -538.97% |
| Cash from Operations | -- | -- | -17.16% | 326.64% | 4.98% |
| Capital Expenditure | -- | -- | -92.91% | -348.24% | 47.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 93.91% | -40.66% | -135.94% |
| Cash from Investing | -- | -- | 84.91% | -45.47% | -136.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00% | 0.00% | 27.03% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 85.35% | 19.51% | 32.14% |
| Cash from Financing | -- | -- | 11.12% | 3.81% | 26.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 93.09% | -23.21% | -139.93% |